CSIMarket Company Name, Ticker, Suppliers, else..
 
China Health Industries Holdings Inc   (NONE: CHHE)
Other Ticker:  
 
 
Price: $0.2750 $-0.09 -25.129%
Day's High: $0.315 Week Perf: -46.34 %
Day's Low: $ 0.28 30 Day Perf: -46.08 %
Volume (M): 2 52 Wk High: $ 2.96
Volume (M$): $ 0 52 Wk Avg: $0.73
Open: $0.32 52 Wk Low: $0.17



 Market Capitalization (Millions $) 18
 Shares Outstanding (Millions) 66
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) -43
 Capital Exp. (TTM) (Millions $) 0

China Health Industries Holdings Inc
China Health Industries Holdings Inc is a company based in China that operates in the health industry. The company is involved in the research, development, manufacture, and distribution of various healthcare products and medicines. They focus on traditional Chinese medicine products, pharmaceuticals, dietary supplements, and medical devices. China Health Industries Holdings Inc aims to provide high-quality, affordable, and effective healthcare solutions to meet the growing demand in China and other international markets. They strive to improve the well-being and quality of life of individuals through their innovative healthcare solutions.


   Company Address: 3199-1 Longxiang Road Harbin City 150028
   Company Phone Number: 451-88100688   Stock Exchange / Ticker: NONE CHHE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



China Health Industries Holdings Inc

China Health Industries Holdings Inc Surpasses Expectations with Top-line Revenue of $0.000087 Million in Q1 2024

all Street journalist, it's crucial to keep track of financial indicators and performance metrics to provide a comprehensive analysis of companies. China Health Industries Holdings Inc, a prominent player in the health industry, recently released its financial results for the January-March 2024 interval, offering insights into its current standing.
During this period, China Health Industries Holdings Inc achieved a significant milestone by reaching a break-even point of $0.00 per share, up from the same period last year where it also stood at $0.00 per share. Furthermore, this indicates an improvement from the prior reporting period where the company reported a loss of $-0.01 per share.
China Health Industries Holdings Inc

CHHE Reports Expanded Deficit of $-0.01 in Recent Fiscal Period, But Why Investors Shouldn't Count Them Out Just Yet



In the world of stock markets, it is not uncommon for companies to experience both highs and lows. China Health Industries Holdings Inc (CHHE) recently announced disappointing results for their most recent fiscal period. However, for savvy investors, this could potentially be an opportune moment to consider investing in this company. Let's take a closer look at the numbers and see why CHHE may have a promising future.
Revenue and Shareholder Value:
During the previous fiscal period, CHHE's revenue plummeted to $0.00 million, causing concern among shareholders. Moreover, the shortfall per share expanded to $-0.01, a significant decrease from the previous reporting season's $0.04 million. Despite these unsettling figures, exploring the underlying reasons behind these setbacks reveals promising signs for the company's long-term prospects.
China Health Industries Holdings Inc

Impressive 11.069% Revenue Surge Demonstrates China Health Industries Holdings Inc's Strong Growth Potential in Q3 2023



China Health Industries Holdings Inc (CHHE) recently announced its financial results for the fiscal period ending September 30, 2023. These results demonstrate the company's ability to achieve top-line growth despite industry-wide revenue reductions. Additionally, CHHE's inventories have declined, indicating potential future demand. This article will outline the facts and set the current financial results into context.
Financial Results Overview:
For the fiscal period ending September 30, 2023, CHHE reported a zero gain of $0.00 per share, compared to a loss of $0.01 per share during the same period a year ago. Sequentially, CHHE improved from a loss of $0.01 per share in the previous quarter. This indicates progress in generating profits and more favorable financial performance.
China Health Industries Holdings Inc

China Health Industries Slays Financial Deficit with a Remarkable $0.01 Per Share! Impressive Success for CHHE in 2023.



The stock market is an ever-changing landscape that can be difficult to navigate, especially when faced with companies experiencing financial troubles. China Health Industries Holdings Inc, a prominent player in the healthcare industry, has had a rough financial span closing in June 2023. This article will analyze their recent financial results, highlighting interesting facts and potential implications for investors.
Earnings and Revenue
During the financial span closing in June 2023, China Health Industries Holdings Inc reported a loss of $-0.01 per share. Although this loss remained unchanged from the previous year, it was still disheartening for investors who had hoped for better financial performance. Additionally, there was no growth in revenue, with the company maintaining $0.02 million, the same as the previous year. However, it is worth noting that there was a sequential increase of 7.536% in revenue from the preceding quarter.






China Health Industries Holdings Inc's Segments
Humankind    100 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com